gadobenic acid
(OCDAWJYGVOLXGZ-VPVMAENOSA-K)
Structure
- SMILES
- OC(=O)CN(C(C(=O)[O-])COCc1ccccc1)CCN(CC(=O)[O-])CCN(CC(=O)O)CC(=O)[O-].CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.[Gd+3]
- Molecular Formula:
- C36H62GdN5O21
- Molecular Weight:
- 1058.150
- Log P:
- -11.0381
- Hydrogen Bond Acceptor:
- 26
- Hydrogen Bond Donor:
- 14
- TPSA:
- 440.3
- CAS Number(s):
- 12700-20-8; 113662-23-0; 127000-20-8
Synonym(s)
1.
gadobenic acid
2.
3,6,9-triaza-12-oxa-3,6,9-tricarboxymethylene-10-carboxy-13-phenyltridecanoic acid, gadolinium
3.
B 19036
4.
B-19036
5.
Gd(BOPTA)2
6.
Gd-BOPTA
7.
MultiHance
8.
gadobenate dimeglumine
9.
gadobenic acid, dimeglumine salt
10.
gadolinium-BOPTA-Dimeg
11.
gadolinium-benzyloxypropionyl tetraacetate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Nausea | FAERS: 405 Canada Vigilance: 22 | Canada Vigilance OFFSIDES US FAERS | |
| 2 | Vomiting | FAERS: 357 Canada Vigilance: 15 | Canada Vigilance US FAERS | |
| 3 | Hypersensitivity | FAERS: 316 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 4 | Urticaria | FAERS: 219 Canada Vigilance: 69 | Canada Vigilance US FAERS | |
| 5 | Pruritus | FAERS: 138 Canada Vigilance: 30 | Canada Vigilance US FAERS | |
| 6 | Erythema | FAERS: 101 Canada Vigilance: 15 | Canada Vigilance OFFSIDES US FAERS | |
| 7 | Sneezing | FAERS: 92 Canada Vigilance: 14 | Canada Vigilance US FAERS | |
| 8 | Anaphylactoid Reaction | FAERS: 83 | US FAERS | |
| 9 | Contrast media reaction | FAERS: 69 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 10 | Dizziness | FAERS: 60 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 11 | Anaphylactic shock | FAERS: 52 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 12 | Cardiac Arrest | FAERS: 50 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Chest discomfort | FAERS: 50 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 14 | Throat irritation | FAERS: 49 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 15 | Headache | FAERS: 48 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Chest Pain | FAERS: 43 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Presyncope | FAERS: 43 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Hypotension | FAERS: 42 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 19 | Flushing | FAERS: 41 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 20 | Burning sensation | FAERS: 35 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 21 | Retching | FAERS: 35 | US FAERS | |
| 22 | Malaise | FAERS: 32 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Pain | FAERS: 29 | OFFSIDES US FAERS | |
| 24 | Feeling abnormal | FAERS: 23 | US FAERS | |
| 25 | Pallor | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 26 | Palpitations | FAERS: 23 | US FAERS | |
| 27 | Syncope | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 28 | Unresponsive to stimuli | FAERS: 23 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | No adverse event | FAERS: 21 | US FAERS | |
| 30 | Tremor | FAERS: 21 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 31 | Anxiety | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 32 | Drug ineffective | FAERS: 20 | US FAERS | |
| 33 | Respiratory arrest | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 34 | Chills | FAERS: 19 | US FAERS | |
| 35 | Tachycardia | FAERS: 19 | US FAERS | |
| 36 | Arthralgia | FAERS: 18 | US FAERS | |
| 37 | Cyanosis | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Depressed Level of Consciousness | FAERS: 18 | US FAERS | |
| 39 | Asthenia | FAERS: 17 | OFFSIDES US FAERS | |
| 40 | Dysgeusia | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 41 | Angioedema | FAERS: 16 | US FAERS | |
| 42 | Dysphonia | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 43 | Injection site pain | FAERS: 16 | US FAERS | |
| 44 | Wheezing | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Abdominal Pain | FAERS: 13 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 46 | Bronchospasm | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | Cold sweat | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Foaming at mouth | FAERS: 13 | US FAERS | |
| 49 | Urinary Incontinence | FAERS: 13 | US FAERS | |
| 50 | Bone pain | FAERS: 12 | OFFSIDES US FAERS | |
| 51 | Bradycardia | FAERS: 12 | US FAERS | |
| 52 | Extravasation | FAERS: 12 | US FAERS | |
| 53 | Eye irritation | FAERS: 12 | US FAERS | |
| 54 | Swelling | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Disorientation | FAERS: 11 | US FAERS | |
| 56 | Lip swelling | FAERS: 11 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 57 | Agitation | FAERS: 10 | US FAERS | |
| 58 | Contrast media allergy | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 59 | Fatigue | FAERS: 10 | US FAERS | |
| 60 | Respiratory distress | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 61 | Blood pressure immeasurable | FAERS: 8 | US FAERS | |
| 62 | Discomfort | FAERS: 8 | US FAERS | |
| 63 | Shock | FAERS: 8 | US FAERS | |
| 64 | Acute myocardial infarction | FAERS: 7 | US FAERS | |
| 65 | Hyperventilation | FAERS: 7 | US FAERS | |
| 66 | Injection Site Reaction | FAERS: 7 | US FAERS | |
| 67 | Nephrogenic Systemic Fibrosis | FAERS: 7 | US FAERS | |
| 68 | Nervousness | FAERS: 7 | US FAERS | |
| 69 | Aphasia | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 70 | Back Pain | FAERS: 6 | US FAERS | |
| 71 | Injection site erythema | FAERS: 6 | US FAERS | |
| 72 | Myalgia | FAERS: 6 | US FAERS | |
| 73 | Oral pruritus | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 74 | Rash erythematous | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 75 | Respiratory Failure | FAERS: 6 | US FAERS | |
| 76 | Visual Impairment | FAERS: 6 | US FAERS | |
| 77 | Choking | FAERS: 5 | US FAERS | |
| 78 | Emotional distress | FAERS: 5 | OFFSIDES US FAERS | |
| 79 | Eye pain | FAERS: 5 | US FAERS | |
| 80 | Incontinence | FAERS: 5 | US FAERS | |
| 81 | Incorrect route of drug administration | FAERS: 5 | US FAERS | |
| 82 | Lethargy | FAERS: 5 | US FAERS | |
| 83 | Myocardial Infarction | FAERS: 5 | US FAERS | |
| 84 | Nasal discomfort | FAERS: 5 | US FAERS | |
| 85 | Vertigo | FAERS: 5 | US FAERS | |
| 86 | Abdominal discomfort | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 87 | Altered state of consciousness | FAERS: 4 | US FAERS | |
| 88 | Blindness | FAERS: 4 | US FAERS | |
| 89 | Epistaxis | FAERS: 4 | US FAERS | |
| 90 | Feeling Cold | FAERS: 4 | US FAERS | |
| 91 | Fibrosis | FAERS: 4 | US FAERS | |
| 92 | Gadolinium deposition disease | FAERS: 4 | US FAERS | |
| 93 | Mental status changes | FAERS: 4 | US FAERS | |
| 94 | Musculoskeletal Pain | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 95 | Musculoskeletal stiffness | FAERS: 4 | OFFSIDES US FAERS | |
| 96 | Neck Pain | FAERS: 4 | US FAERS | |
| 97 | Oropharyngeal pain | FAERS: 4 | US FAERS | |
| 98 | Peripheral swelling | FAERS: 4 | US FAERS | |
| 99 | Skin tightness | FAERS: 4 | OFFSIDES US FAERS | |
| 100 | Somnolence | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | Tinnitus | FAERS: 4 | US FAERS | |
| 102 | Toxicity to various agents | FAERS: 4 | US FAERS | |
| 103 | Accidental exposure to product | FAERS: 3 | US FAERS | |
| 104 | Accidental overdose | FAERS: 3 | US FAERS | |
| 105 | Alopecia | FAERS: 3 | US FAERS | |
| 106 | Amnesia | FAERS: 3 | US FAERS | |
| 107 | Anoxic Encephalopathy | FAERS: 3 | US FAERS | |
| 108 | Facial paralysis | FAERS: 3 | US FAERS | |
| 109 | Hypoxia | FAERS: 3 | US FAERS | |
| 110 | Increased upper airway secretion | FAERS: 3 | US FAERS | |
| 111 | Inflammation | FAERS: 3 | US FAERS | |
| 112 | Infusion Site Extravasation | FAERS: 3 | US FAERS | |
| 113 | Infusion site erythema | FAERS: 3 | US FAERS | |
| 114 | Injection site irritation | FAERS: 3 | US FAERS | |
| 115 | Muscle Rigidity | FAERS: 3 | US FAERS | |
| 116 | Mydriasis | FAERS: 3 | US FAERS | |
| 117 | Myopathy | FAERS: 3 | US FAERS | |
| 118 | Necrosis | FAERS: 3 | US FAERS | |
| 119 | Perineal pain | FAERS: 3 | US FAERS | |
| 120 | Pharyngolaryngeal Pain | FAERS: 3 | US FAERS | |
| 121 | Product quality issue | FAERS: 3 | US FAERS | |
| 122 | Pulmonary Embolism | FAERS: 3 | US FAERS | |
| 123 | Stomatitis | FAERS: 3 | US FAERS | |
| 124 | Thrombophlebitis | FAERS: 3 | US FAERS | |
| 125 | Thrombosis | FAERS: 3 | US FAERS | |
| 126 | Vitreous floaters | FAERS: 3 | US FAERS | |
| 127 | Weight decreased | FAERS: 3 | US FAERS | |
| 128 | Acute kidney injury | FAERS: 2 | US FAERS | |
| 129 | Adverse event | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 130 | Anosmia | FAERS: 2 | US FAERS | |
| 131 | Aphonia | FAERS: 2 | US FAERS | |
| 132 | Asphyxia | FAERS: 2 | OFFSIDES US FAERS | |
| 133 | Asthma | FAERS: 2 | US FAERS | |
| 134 | Carotid pulse decreased | FAERS: 2 | OFFSIDES US FAERS | |
| 135 | Caustic injury | FAERS: 2 | OFFSIDES US FAERS | |
| 136 | Cellulitis | FAERS: 2 | US FAERS | |
| 137 | Choking sensation | FAERS: 2 | US FAERS | |
| 138 | Conjunctivitis | FAERS: 2 | US FAERS | |
| 139 | Contraindicated product administered | FAERS: 2 | US FAERS | |
| 140 | Contrast media deposition | FAERS: 2 | US FAERS | |
| 141 | Diplopia | FAERS: 2 | US FAERS | |
| 142 | Drug administration error | FAERS: 2 | US FAERS | |
| 143 | Dysarthria | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 144 | Dyspepsia | FAERS: 2 | US FAERS | |
| 145 | Electromechanical dissociation | FAERS: 2 | US FAERS | |
| 146 | Epilepsy | FAERS: 2 | US FAERS | |
| 147 | Feeling of body temperature change | FAERS: 2 | US FAERS | |
| 148 | Flank Pain | FAERS: 2 | US FAERS | |
| 149 | Glossitis | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 150 | Grip strength decreased | FAERS: 2 | US FAERS | |
| 151 | Incoherent | FAERS: 2 | US FAERS | |
| 152 | Incorrect dose administered | FAERS: 2 | US FAERS | |
| 153 | Incorrect route of product administration | FAERS: 2 | US FAERS | |
| 154 | Injection site extravasation | FAERS: 2 | US FAERS | |
| 155 | Injection site mass | FAERS: 2 | US FAERS | |
| 156 | Injection site urticaria | FAERS: 2 | US FAERS | |
| 157 | Internal injury | FAERS: 2 | US FAERS | |
| 158 | Memory impairment | FAERS: 2 | US FAERS | |
| 159 | Mouth swelling | FAERS: 2 | US FAERS | |
| 160 | Muscle tightness | FAERS: 2 | OFFSIDES US FAERS | |
| 161 | Myosclerosis | FAERS: 2 | OFFSIDES US FAERS | |
| 162 | Nasal pruritus | FAERS: 2 | US FAERS | |
| 163 | No reaction on previous exposure to drug | FAERS: 2 | US FAERS | |
| 164 | Nystagmus | FAERS: 2 | US FAERS | |
| 165 | Ocular discomfort | FAERS: 2 | US FAERS | |
| 166 | Oropharyngeal discomfort | FAERS: 2 | US FAERS | |
| 167 | Phlebitis | FAERS: 2 | US FAERS | |
| 168 | Pregnancy | FAERS: 2 | US FAERS | |
| 169 | Restlessness | FAERS: 2 | US FAERS | |
| 170 | Screaming | FAERS: 2 | OFFSIDES US FAERS | |
| 171 | Skin hypertrophy | FAERS: 2 | OFFSIDES US FAERS | |
| 172 | Staring | FAERS: 2 | US FAERS | |
| 173 | Stress | FAERS: 2 | OFFSIDES US FAERS | |
| 174 | Stridor | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 175 | Stupor | FAERS: 2 | US FAERS | |
| 176 | Subcutaneous nodule | FAERS: 2 | US FAERS | |
| 177 | Therapeutic product effect decreased | FAERS: 2 | US FAERS | |
| 178 | Troponin increased | FAERS: 2 | OFFSIDES US FAERS | |
| 179 | Unevaluable event | FAERS: 2 | OFFSIDES US FAERS | |
| 180 | VIIth nerve paralysis | FAERS: 2 | US FAERS | |
| 181 | nervous system disorder | FAERS: 2 | US FAERS | |
| 182 | Abasia | FAERS: 1 | US FAERS | |
| 183 | Abscess soft tissue | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 184 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 185 | Acute Coronary Syndrome | FAERS: 1 | US FAERS | |
| 186 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 187 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 188 | Apathy | FAERS: 1 | US FAERS | |
| 189 | Application site pruritus | FAERS: 1 | US FAERS | |
| 190 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 191 | Autoimmune thyroiditis | FAERS: 1 | US FAERS | |
| 192 | Biopsy bone abnormal | FAERS: 1 | US FAERS | |
| 193 | Biopsy brain abnormal | FAERS: 1 | US FAERS | |
| 194 | Biopsy skin abnormal | FAERS: 1 | US FAERS | |
| 195 | Bladder pain | FAERS: 1 | US FAERS | |
| 196 | Bladder spasm | FAERS: 1 | US FAERS | |
| 197 | Blood blister | FAERS: 1 | US FAERS | |
| 198 | Blood creatine phosphokinase increased | FAERS: 1 | US FAERS | |
| 199 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 200 | Blood heavy metal increased | FAERS: 1 | US FAERS | |
| 201 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 202 | Blood pressure fluctuation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 203 | Brain Hypoxia | FAERS: 1 | US FAERS | |
| 204 | Cachexia | FAERS: 1 | US FAERS | |
| 205 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 206 | Chromaturia | FAERS: 1 | US FAERS | |
| 207 | Chronic Fatigue Syndrome | FAERS: 1 | US FAERS | |
| 208 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 209 | Clumsiness | FAERS: 1 | US FAERS | |
| 210 | Contrast media toxicity | FAERS: 1 | US FAERS | |
| 211 | Deafness | FAERS: 1 | US FAERS | |
| 212 | Depressed mood | FAERS: 1 | US FAERS | |
| 213 | Device Failure | FAERS: 1 | US FAERS | |
| 214 | Drug effect variable | FAERS: 1 | US FAERS | |
| 215 | Drug level increased | FAERS: 1 | US FAERS | |
| 216 | Drug screen positive | FAERS: 1 | US FAERS | |
| 217 | Dry skin | FAERS: 1 | OFFSIDES US FAERS | |
| 218 | Ear discomfort | FAERS: 1 | US FAERS | |
| 219 | Electrocardiogram change | FAERS: 1 | US FAERS | |
| 220 | Erythema Multiforme | FAERS: 1 | US FAERS | |
| 221 | Excessive eye blinking | FAERS: 1 | US FAERS | |
| 222 | Fibromyalgia | FAERS: 1 | US FAERS | |
| 223 | Fumbling | FAERS: 1 | US FAERS | |
| 224 | Gaze palsy | FAERS: 1 | US FAERS | |
| 225 | General physical health deterioration | FAERS: 1 | OFFSIDES US FAERS | |
| 226 | Hair metal test abnormal | FAERS: 1 | US FAERS | |
| 227 | Head discomfort | FAERS: 1 | US FAERS | |
| 228 | Hemiparesis | FAERS: 1 | US FAERS | |
| 229 | Hypertensive crisis | FAERS: 1 | US FAERS | |
| 230 | Hypoaesthesia facial | FAERS: 1 | US FAERS | |
| 231 | Hypoperfusion | FAERS: 1 | US FAERS | |
| 232 | Immediate post-injection reaction | FAERS: 1 | US FAERS | |
| 233 | Infarction | FAERS: 1 | US FAERS | |
| 234 | Infusion site rash | FAERS: 1 | US FAERS | |
| 235 | Injection site coldness | FAERS: 1 | US FAERS | |
| 236 | Injection site necrosis | FAERS: 1 | US FAERS | |
| 237 | Injection site pruritus | FAERS: 1 | US FAERS | |
| 238 | Injection site vesicles | FAERS: 1 | US FAERS | |
| 239 | Joint stiffness | FAERS: 1 | OFFSIDES US FAERS | |
| 240 | Laryngospasm | FAERS: 1 | US FAERS | |
| 241 | Leukopenia | FAERS: 1 | US FAERS | |
| 242 | Lid sulcus deepened | FAERS: 1 | US FAERS | |
| 243 | Limb discomfort | FAERS: 1 | US FAERS | |
| 244 | Lymphangitis | FAERS: 1 | US FAERS | |
| 245 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 246 | Medical device complication | FAERS: 1 | US FAERS | |
| 247 | Medication residue present | FAERS: 1 | US FAERS | |
| 248 | Mental impairment | FAERS: 1 | US FAERS | |
| 249 | Multiple Chemical Sensitivity | FAERS: 1 | US FAERS | |
| 250 | Multiple use of single-use product | FAERS: 1 | US FAERS | |
| 251 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 252 | Myoclonus | FAERS: 1 | US FAERS | |
| 253 | Nephrogenic Fibrosing Dermopathy | FAERS: 1 | OFFSIDES US FAERS | |
| 254 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 255 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 256 | Nontherapeutic agent urine positive | FAERS: 1 | US FAERS | |
| 257 | Nuclear magnetic resonance imaging abdominal | FAERS: 1 | US FAERS | |
| 258 | Overdose | FAERS: 1 | US FAERS | |
| 259 | Pain of skin | FAERS: 1 | OFFSIDES US FAERS | |
| 260 | Paranasal sinus discomfort | FAERS: 1 | US FAERS | |
| 261 | Parasomnia | FAERS: 1 | US FAERS | |
| 262 | Pharyngeal swelling | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 263 | Photophobia | FAERS: 1 | US FAERS | |
| 264 | Pneumonia | FAERS: 1 | US FAERS | |
| 265 | Poisoning | FAERS: 1 | US FAERS | |
| 266 | Poor quality sleep | FAERS: 1 | US FAERS | |
| 267 | Post procedural complication | FAERS: 1 | US FAERS | |
| 268 | Procedural complication | FAERS: 1 | US FAERS | |
| 269 | Product administration error | FAERS: 1 | US FAERS | |
| 270 | Product physical issue | FAERS: 1 | US FAERS | |
| 271 | Product storage error | FAERS: 1 | US FAERS | |
| 272 | Pulmonary congestion | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 273 | Renal pain | FAERS: 1 | US FAERS | |
| 274 | Right ventricular failure | FAERS: 1 | US FAERS | |
| 275 | Seizure like phenomena | FAERS: 1 | US FAERS | |
| 276 | Similar reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 277 | Sinus Arrhythmia | FAERS: 1 | US FAERS | |
| 278 | Skin Ulcer | FAERS: 1 | US FAERS | |
| 279 | Skin Wrinkling | FAERS: 1 | OFFSIDES US FAERS | |
| 280 | Skin lesion | FAERS: 1 | OFFSIDES US FAERS | |
| 281 | Skin texture abnormal | FAERS: 1 | US FAERS | |
| 282 | Status Asthmaticus | FAERS: 1 | US FAERS | |
| 283 | Thermal burn | FAERS: 1 | US FAERS | |
| 284 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 285 | Urinary Retention | FAERS: 1 | US FAERS | |
| 286 | Uterine spasm | FAERS: 1 | US FAERS | |
| 287 | Vasculitis | FAERS: 1 | US FAERS | |
| 288 | Venous occlusion | FAERS: 1 | US FAERS | |
| 289 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 290 | Visceral Pain | FAERS: 1 | US FAERS | |
| 291 | Visual disturbance | FAERS: 1 | US FAERS | |
| 292 | Amphetamines | OFFSIDES | ||
| 293 | Amputation | OFFSIDES | ||
| 294 | Anhedonia | OFFSIDES | ||
| 295 | Bone density decreased | OFFSIDES | ||
| 296 | Bronchopneumonia | OFFSIDES | ||
| 297 | Contracture | OFFSIDES | ||
| 298 | Demyelination | OFFSIDES | ||
| 299 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 300 | Dystrophic calcification | OFFSIDES | ||
| 301 | Eschar | OFFSIDES | ||
| 302 | Exfoliative rash | OFFSIDES | ||
| 303 | Extremity contracture | OFFSIDES | ||
| 304 | Formication | OFFSIDES | ||
| 305 | Growing pains | OFFSIDES | ||
| 306 | Hyperpigmentation | OFFSIDES | ||
| 307 | Impaired self-care | OFFSIDES | ||
| 308 | Induration | OFFSIDES | ||
| 309 | Infusion site mobility decreased | OFFSIDES | ||
| 310 | Injection related reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 311 | Joint Range of Motion Decreased | OFFSIDES | ||
| 312 | Leukoencephalopathy | OFFSIDES | ||
| 313 | Lichenification | OFFSIDES | ||
| 314 | Life expectancy shortened | OFFSIDES | ||
| 315 | Livedo Reticularis | OFFSIDES | ||
| 316 | Lymphedema | OFFSIDES | ||
| 317 | Metaplasia | OFFSIDES | ||
| 318 | Muscle Fatigue | OFFSIDES | ||
| 319 | Muscle Weakness | OFFSIDES | ||
| 320 | Muscle fibrosis | OFFSIDES | ||
| 321 | Neuralgia | OFFSIDES | ||
| 322 | Nodule on extremity | OFFSIDES | ||
| 323 | Ocular icterus | OFFSIDES | ||
| 324 | Open wound | OFFSIDES | ||
| 325 | Palmar erythema | Canada Vigilance: 1 | Canada Vigilance | |
| 326 | Papule | Canada Vigilance: 1 | Canada Vigilance | |
| 327 | Petechiae | Canada Vigilance: 1 | Canada Vigilance | |
| 328 | Physical disability | OFFSIDES | ||
| 329 | Pinguecula | OFFSIDES | ||
| 330 | Post inflammatory pigmentation change | OFFSIDES | ||
| 331 | Postoperative renal failure | OFFSIDES | ||
| 332 | Productive Cough | Canada Vigilance: 1 | Canada Vigilance | |
| 333 | Pulmonary Hypertension | OFFSIDES | ||
| 334 | Pulmonary function test decreased | OFFSIDES | ||
| 335 | Quadriparesis | OFFSIDES | ||
| 336 | Quality of life decreased | OFFSIDES | ||
| 337 | Respiratory tract congestion | Canada Vigilance: 1 | Canada Vigilance | |
| 338 | Sclerodactylia | OFFSIDES | ||
| 339 | Sinus Tachycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 340 | Skin Erosion | OFFSIDES | ||
| 341 | Skin Induration | OFFSIDES | ||
| 342 | Skin necrosis | OFFSIDES | ||
| 343 | Spinal column stenosis | OFFSIDES | ||
| 344 | Spondylitis | OFFSIDES | ||
| 345 | Stasis dermatitis | OFFSIDES | ||
| 346 | Xerosis | OFFSIDES | ||
| 347 | effusion | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.